Objective Few reports have described the treatment outcome of osteosarcoma using
radiotherapy. We evaluated the efficacy of radiotherapy and gemcitabine and docetaxel …

Background We evaluated the efficacy of gemcitabine and docetaxel chemotherapy (GEM+
DOC) in children and adolescents with recurrent or refractory osteosarcoma. Methods Data …

It remains unclear how to optimally incorporate gemcitabine and docetaxel into the
management of patients with recurrent osteosarcoma. We describe 4 pediatric patients with …

BACKGROUND The goal of the current study was to define the clinical features and
outcome of recurrent osteosarcoma (OS) in children and young adults initially treated with …

Background Efficacy of gemcitabine and docetaxel (GEM+ DOC) chemotherapy in patients
with recurrent or refractory osteosarcoma was evaluated. Methods Data of 53 patients from 9 …

Osteosarcoma is the most frequent primary bone tumor. Advances in combination
chemotherapy and surgical technique have greatly improved the survival of patients with …

Purpose In this study, we investigated the clinical characteristics and treatment results of
osteosarcoma during the past 7 years, and evaluated the role of high dose chemotherapy …

PURPOSE: We analyzed the clinical features and outcome of patients with radiation-
associated osteosarcoma treated during the era of contemporary chemotherapy. PATIENTS …

Purpose Chemotherapy during radiation and/or bone‐seeking radioisotope therapy (153‐
samarium; 1 mCi/kg) during radiation may improve osteosarcoma cancer control. Patients …

BACKGROUND. The combination of gemcitabine and docetaxel has demonstrated promise
in sarcomas diagnosed in adults. In the current study, the toxicity and efficacy of this …